Levotuss

Levodropropizine, the active ingredient in Levotuss, is an antitussive presented as an oral formulation for oral use. It is used to relieve cough in patients with acute, chronic or infection‑related irritation of the respiratory tract. GNH USA supplies Levotuss as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodropropizine acts on the peripheral cough pathway to reduce the cough reflex. - Acute cough: provides symptomatic relief of non‑productive cough episodes. - Chronic cough: helps decrease cough frequency in persistent cough conditions. - Cough associated with upper respiratory tract infections: alleviates irritation‑driven cough.

Levodropropizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: transient light‑headedness. - Headache: occasional mild headache. - Dry mouth: reduced salivation. - Abdominal discomfort: mild stomach pain. - Altered taste: temporary metallic or bitter taste.

Serious or Rare Side Effects: - Allergic reactions: rash, pruritus, or urticaria. - Angioedema: swelling of face, lips or tongue. - Severe hepatic injury: rare cases of liver enzyme elevation. - Anaphylaxis: life‑threatening hypersensitivity. - Blood dyscrasias: rare hematologic abnormalities.

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in severe renal impairment. - Monitor for hypersensitivity: discontinue if allergic signs appear. - Avoid in patients with known levodropropizine allergy. - Use with caution in pregnancy: limited safety data available. - Use with caution while breastfeeding: unknown excretion in milk. - Store at room temperature: keep in the original pack, protect from moisture.

Levodropropizine may interact with other medicines; review the following.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase levodropropizine exposure. - Concurrent use with other antitussives: risk of additive cough suppression.

Moderate Interactions (Monitor Closely): - Antihistamines: possible enhanced sedative effect. - Bronchodilators: monitor for altered efficacy. - Alcohol: may increase dizziness or gastrointestinal upset.